SCHEMBL7983014

SCHEMBL7983014

COc1ccc2[nH]c(=O)c3cncn3c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 2/20 0.46
GABRA1 P14867 1/20 0.46
DCLK1 O15075 1/20 0.43
MAP4K4 O95819 1/20 0.43
CSF1R P07333 1/20 0.43
PIM1 P11309 1/20 0.43
CSNK1D P48730 1/20 0.43
CDK5 Q00535 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
STK17A Q9UEE5 1/20 0.43
BRD9 Q9H8M2 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
ADORA3 P0DMS8 3/20 0.40
ADORA1 P30542 2/20 0.40
ACHE P22303 1/20 0.40
PDE3B Q13370 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986801 0.80 GRIN2D (0.50) GABRA5BRD9ALDH1A1KDM4EPDE3B
SCHEMBL31026820 0.79 PARP1 (0.49) ALDH1A1KDM4EGAALCKMEN1
SCHEMBL2468642 0.78 DAO (0.46) GABRA5GABRA1MAP4K4ADORA3ADORA1
SCHEMBL29235466 0.78 TP53 (0.46) GABRA5GABRA1MAP4K4CSF1RPIM1
SCHEMBL7982949 0.78 GABRA5 (0.36) GABRA5GABRA1MAP4K4POLBHTR1A
SCHEMBL21755742 0.77 PARP1 (0.59) DCLK1MAP4K4CSF1RPIM1CSNK1D
SCHEMBL7982902 0.76 GRIN2D (0.54) GABRA5ALDH1A1KDM4EPDE3BPDE3A
SCHEMBL29235602 0.75 PARP1 (0.45) ALDH1A1KDM4EHPGD
SCHEMBL4763948 0.74 PARP1 (0.59) GABRA5GABRA1DCLK1MAP4K4CSF1R
SCHEMBL30095396 0.74 PARP1 (0.59) GABRA5GABRA1DCLK1MAP4K4CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed